Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171353
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2005-09-12
Brief Title:
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Study to Describe Vascular and Renal Effects and Safety of Valsartan 80 and 160 mg in Arterial Hypertension Patients
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
One hundred twenty patients with arterial hypertension and albuminuria some amount of albumin in urine are given valsartan 80 mg and then160 mg to normalize blood pressure Hydrochlorothiazide diuretic 125-25 mg added if necessary
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None